ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,340.80
0.33%
Dow Jones
38,884.26
0.08%
Gold vs US Dollar
2,307.91
-0.31%
Brent Oil
81.93
-1.13%
Bitcoin
62,344.70
0.02%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Chinook Therapeutics Inc (KDNY)

  7. Chinook Therapeutics Inc (KDNY) News

Chinook Therapeutics (KDNY)

Chinook Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KDNY
DateTimeSourceHeadlineSymbolCompany
22/11/202321:15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:KDNYChinook Therapeutics Inc
21/08/202318:21Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:KDNYChinook Therapeutics Inc
17/08/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:KDNYChinook Therapeutics Inc
11/08/202322:02Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
11/08/202322:00Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:58Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:56Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:54Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:52Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:50Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:48Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:46Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:44Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:42Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:39Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:35Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KDNYChinook Therapeutics Inc
11/08/202321:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KDNYChinook Therapeutics Inc
07/08/202321:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KDNYChinook Therapeutics Inc
03/08/202321:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KDNYChinook Therapeutics Inc
02/08/202300:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KDNYChinook Therapeutics Inc
01/08/202312:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KDNYChinook Therapeutics Inc
28/07/202313:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KDNYChinook Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:KDNY

Your Recent History

LSE
POS
Plexus
LSE
AAZ
Anglo Asian Mining
LSE
BOO
Boohoo
LSE
CHLL
Chill Brands
LSE
BARC
Barclays
LSE
KEFI
Kefi Gold And Copper
LSE
APH
Alliance Pharma
LSE
TERN
Tern
LSE
AGL
Angle
LSE
RR.
Rolls-royce
LSE
MBT
Mobile Tornado
LSE
BGO
Bango
LSE
CSFS
Cornerstone Fs
LSE
ASC
Asos
LSE
GGP
Greatland Gold
LSE
BP.
Bp
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved